Warp Sciences Emerges With $215M at $865M Valuation — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Warp Sciences emerged from stealth with $215 million at an $865 million post-money valuation.
- Kevin Weil founded Warp Sciences to use AI to speed drug development; he is a former OpenAI CPO who led OpenAI’s AI-for-science efforts.
Why it matters: Kevin Weil is taking his OpenAI AI-for-science experience into a dedicated drug-development company. The disclosed $215 million backing and $865 million post-money valuation quantify the resources and market value attached to Warp Sciences as it emerges from stealth under his leadership.
Ask SkimNews
